At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 27 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
In plain English
This registry study, run by the Medical University of Graz, is collecting information to better understand a pattern of lung blood vessel problems (called the 'pulmonary vascular phenotype') in people with chronic obstructive pulmonary disease (COPD). COPD is a lung condition that makes breathing difficult, and some people with COPD also develop pulmonary hypertension, which means high blood pressure in the blood vessels of the lungs. Taking part means your information is collected and studied, rather than testing a new treatment.
Who can take part
- You have a clinical diagnosis of COPD (a lung condition that makes breathing difficult).
- You have had a test called right heart catheterisation, which measures pressures and blood flow in the heart and lung blood vessels.
- You are aged 18 or over.
Who may not be able to
- Children and young people under 18.
- People who do not have COPD or have not had a right heart catheterisation test.
What taking part involves
- • This is a registry study, so it collects information about participants rather than testing a treatment. What taking part involves beyond data collection: Not stated — ask the trial team.
Time commitment: Number of visits, how long the study lasts, and what taking part involves: Not stated — ask the trial team.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 1,000
- Started
- 2025-09-01
- Last checked
- 2026-01
Plain English Summary
What is this study?
- • Testing a new treatment for chronic obstructive pulmonary disease (copd)
- • Clinical study - 1,000 participants
- • Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with chronic obstructive pulmonary disease (copd)
Where?
- • Sheffield - University of Sheffield
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓clinical diagnosis of COPD
- ✓right heart catheterization including mPAP (Mean lung Artery Pressure), PVR (lung Vascular Resistance),...
- ✓age \>= 18 years
Who cannot take part
- ✗pediatric patients
- ✗no COPD or no RHC
See the full criteria
Where Is This Study? (1 UK site)
University of Sheffield
Sheffield, United Kingdom